Tag: Pharma stakeholders
Sub-committee of DTAB on FDCs to hear stakeholders from April 19
The sub-committee, constituted for examining the fixed dose combinations (FDCs) considered as irrational by Prof Kokate Committee, has invited concerned stakeholders for...
Pharma stakeholders raise concerns about price increase of PVC granules
The rising prices of PVC granules in India are adversely affecting finished formulations of pharma products and it is also affecting the...
D&C Act 1940 should be re-framed: Pharma stakeholders
Pharma industry stakeholders feel that the Drugs and Cosmetics Act 1940 needs to be re-framed to streamline drug regulatory affairs in India.